TWO DOSES OF ASTRAZENECA, COVISHIELD NOT THAT EFFECTIVE: STUDY
20 Mar 2021 02:45 AM IST
A two-dose regimen of the ChAdOx1 (Oxford-AstraZeneca vaccine) and Covishield vaccine did not show protection against mild-to-moderate Covid-19 due to the B.1.351 variant, according to a study published in The New England Journal of Medicine. The findings came from a multicentre, double-blind, randomised, and controlled trial which involved HIV-negative adults